<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39416809</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>17</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>18</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1432-2277</ISSN><JournalIssue CitedMedium="Internet"><Volume>37</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Transplant international : official journal of the European Society for Organ Transplantation</Title><ISOAbbreviation>Transpl Int</ISOAbbreviation></Journal><ArticleTitle>Non-Standard Risk Donors and Risk of Donor-Derived Infections: From Evaluation to Therapeutic Management.</ArticleTitle><Pagination><StartPage>12803</StartPage><MedlinePgn>12803</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">12803</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/ti.2024.12803</ELocationID><Abstract><AbstractText>Expected and unexpected donor-derived infections are a rare complication of solid organ transplantation, but can result in significant morbidity and mortality. Over the last years, the growing gap existing between patients on the waiting list and available organs has favored the use of organs from donors with suspected or confirmed infections, thanks to the improvement of risk mitigation strategies against transmission of well recognized and emerging infections. Given the recent developments, the particular interest of this review is to summarize data on how to maximize utilization of HIV+ donors in HIV+ recipients, the use of HCV-viremic donors and HBV positive donors. This article also covers the implications for recipient of organs from donors with bacteremia and the challenge of multidrug resistant (MDR) infections. Lastly this review describes emerging risks associated with recent Coronavirus Disease-2019 (COVID-19) pandemics.</AbstractText><CopyrightInformation>Copyright © 2024 Grossi, Wolfe and Peghin.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Grossi</LastName><ForeName>Paolo A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Infectious and Tropical Diseases Unit, Department of Medicine and Surgery, University of Insubria, Varese, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wolfe</LastName><ForeName>Cameron</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Duke University School of Medicine, Durham, NC, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peghin</LastName><ForeName>Maddalena</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Infectious and Tropical Diseases Unit, Department of Medicine and Surgery, University of Insubria, Varese, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Transpl Int</MedlineTA><NlmUniqueID>8908516</NlmUniqueID><ISSNLinking>0934-0874</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014019" MajorTopicYN="Y">Tissue Donors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016377" MajorTopicYN="N">Organ Transplantation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006526" MajorTopicYN="N">Hepatitis C</DescriptorName><QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D046148" MajorTopicYN="N">Donor Selection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006509" MajorTopicYN="N">Hepatitis B</DescriptorName><QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">HIV</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">bacteremia</Keyword><Keyword MajorTopicYN="N">donor derived infections</Keyword><Keyword MajorTopicYN="N">emerging pathogens</Keyword><Keyword MajorTopicYN="N">hepatitis</Keyword><Keyword MajorTopicYN="N">multidrug resistant</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>17</Day><Hour>10</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>17</Day><Hour>10</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>17</Day><Hour>4</Hour><Minute>59</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39416809</ArticleId><ArticleId IdType="pmc">PMC11479921</ArticleId><ArticleId IdType="doi">10.3389/ti.2024.12803</ArticleId><ArticleId IdType="pii">12803</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kaul DR, Vece G, Blumberg E, La Hoz RM, Ison MG, Green M, et al. Ten Years of Donor-Derived Disease: A Report of the Disease Transmission Advisory Committee. Am J Transpl (2021) 21(2):689–702. 10.1111/ajt.16178</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ajt.16178</ArticleId><ArticleId IdType="pubmed">32627325</ArticleId></ArticleIdList></Reference><Reference><Citation>Penumarthi LR, La Hoz RM, Wolfe CR, Jackson BR, Mehta AK, Malinis M, et al. Cryptococcus Transmission Through Solid Organ Transplantation in the United States: A Report From the Ad Hoc Disease Transmission Advisory Committee. Am J Transpl (2021) 21(5):1911–23. 10.1111/ajt.16433</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ajt.16433</ArticleId><ArticleId IdType="pmc">PMC8096655</ArticleId><ArticleId IdType="pubmed">33290629</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorsline CA, Tyler RS, Sigler RK, Wolfe CR, Harris CE, Kumar RN. They Paged Me what?: A Transplant Infectious Disease Guide to Donor Calls. Transpl Infect Dis (2023) 25:e14172. 10.1111/tid.14172</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tid.14172</ArticleId><ArticleId IdType="pubmed">37937964</ArticleId></ArticleIdList></Reference><Reference><Citation>Peghin M, Grossi PA. Donor-Derived Infections in Solid Organ Transplant Recipients. Curr Opin Organ Transpl (2023) 28(5):384–90. 10.1097/MOT.0000000000001094</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MOT.0000000000001094</ArticleId><ArticleId IdType="pmc">PMC10597443</ArticleId><ArticleId IdType="pubmed">37555801</ArticleId></ArticleIdList></Reference><Reference><Citation>Saha A, Browning C, Dandamudi R, Barton K, Graepel K, Cullity M, et al. Donor-Derived Ehrlichiosis: 2 Clusters Following Solid Organ Transplantation. Clin Infect Dis (2022) 74(5):918–23. 10.1093/cid/ciab667</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab667</ArticleId><ArticleId IdType="pmc">PMC8906657</ArticleId><ArticleId IdType="pubmed">34329411</ArticleId></ArticleIdList></Reference><Reference><Citation>Danziger-Isakov L, Kumar D, AST ID Community of Practice. Vaccination of Solid Organ Transplant Candidates and Recipients: Guidelines From the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transpl (2019) 33(9):e13563. 10.1111/ctr.13563</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ctr.13563</ArticleId><ArticleId IdType="pubmed">31002409</ArticleId></ArticleIdList></Reference><Reference><Citation>Russo FP, Vigano M, Stock P, Ferrarese A, Pugliese N, Burra P, et al. HBV-Positive and HIV-Positive Organs in Transplantation: A Clinical Guide for the Hepatologist. J Hepatol (2022) 77(2):503–15. 10.1016/j.jhep.2022.03.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2022.03.007</ArticleId><ArticleId IdType="pubmed">35398460</ArticleId></ArticleIdList></Reference><Reference><Citation>Loggi E, Micco L, Ercolani G, Cucchetti A, Bihl FK, Grazi GL, et al. Liver Transplantation from Hepatitis B Surface Antigen Positive Donors: A Safe Way to Expand the Donor Pool. J Hepatol (2012) 56(3):579–85. 10.1016/j.jhep.2011.09.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2011.09.016</ArticleId><ArticleId IdType="pubmed">22027583</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatnagar A, Prakash S, Lymberopoulos P, Goff C, Shaikh A, Kim D, et al. Transplanting Hepatitis B Surface Antigen-Positive Livers in the United States: Outcomes and Opportunities. Am J Transpl (2023) 23:1221–6. 10.1016/j.ajt.2023.04.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajt.2023.04.024</ArticleId><ArticleId IdType="pubmed">37116583</ArticleId></ArticleIdList></Reference><Reference><Citation>
Centro Nazionale Trapianti. Valutazione Dell’idoneità Del Donatore in Relazione A Patologie Infettive (2024). Available from: https://www.trapianti.salute.gov.it/imgs/C_17_cntPubblicazioni_620_allegato.pdf (Accessed January, 2024).
</Citation></Reference><Reference><Citation>European Directorate for the Quality of Medicines &amp; HealthCare (EDQM). Guide on Quality and Safety of Organs for Transplantation. 8th ed. Strasbourg, France: European Directorate for the Quality of Medicines &amp; HealthCare (EDQM) (2022).</Citation></Reference><Reference><Citation>Jones JM, Kracalik I, Levi ME, Bowman JS, Berger JJ, Bixler D, et al. Assessing Solid Organ Donors and Monitoring Transplant Recipients for Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Infection — U.S. Public Health Service Guideline, 2020. MMWR Recomm Rep (2020) 69(4):1–16. 10.15585/mmwr.rr6904a1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.rr6904a1</ArticleId><ArticleId IdType="pmc">PMC7337549</ArticleId><ArticleId IdType="pubmed">32584804</ArticleId></ArticleIdList></Reference><Reference><Citation>Coffin CS, Zhou K, Terrault NA. New and Old Biomarkers for Diagnosis and Management of Chronic Hepatitis B Virus Infection. Gastroenterology (2019) 156(2):355–68. 10.1053/j.gastro.2018.11.037</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2018.11.037</ArticleId><ArticleId IdType="pmc">PMC6433165</ArticleId><ArticleId IdType="pubmed">30472225</ArticleId></ArticleIdList></Reference><Reference><Citation>Te H, Doucette K. Viral Hepatitis: Guidelines by the American Society of Transplantation Infectious Disease Community of Practice. Clin Transpl (2019) 33(9):e13514. 10.1111/ctr.13514</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ctr.13514</ArticleId><ArticleId IdType="pubmed">30817047</ArticleId></ArticleIdList></Reference><Reference><Citation>Singal AK, Reddy KR, Nguyen MH, Younossi Z, Kwo P, Kuo YF. Use and Outcomes of Hepatitis B Virus-Positive Grafts for Kidney or Heart Transplantation in the United States From 1999 to 2021. Transplantation (2023) 108:693–702. 10.1097/TP.0000000000004759</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TP.0000000000004759</ArticleId><ArticleId IdType="pubmed">37953470</ArticleId></ArticleIdList></Reference><Reference><Citation>Carnemolla BT, Kutzler HL, Kuzaro HA, Morgan G, Serrano OK, Ye X, et al. Use of Hepatitis B Viremic Donors in Kidney Transplant Recipients: A Single Center Experience. Transpl Infect Dis (2022) 24(4):e13872. 10.1111/tid.13872</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tid.13872</ArticleId><ArticleId IdType="pubmed">35642883</ArticleId></ArticleIdList></Reference><Reference><Citation>Len O, Los-Arcos I, Aguado JM, Blanes M, Bodro M, Carratala J, et al. Executive Summary of the Consensus Statement of the Transplant Infection Study Group (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the National Transplant Organization (ONT) on the Selection Criteria of Donors of Solid Organs in Relation to Infectious Diseases. Enferm Infecc Microbiol Clin (Engl Ed) (2020) 38(8):379–89. 10.1016/j.eimc.2019.10.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eimc.2019.10.016</ArticleId><ArticleId IdType="pubmed">31870646</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi Y, Choi JY, Yi NJ, Lee K, Mori S, Hong G, et al. Liver Transplantation for HBsAg-Positive Recipients Using Grafts from HBsAg-Positive Deceased Donors. Transpl Int (2013) 26(12):1173–83. 10.1111/tri.12177</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tri.12177</ArticleId><ArticleId IdType="pubmed">24131436</ArticleId></ArticleIdList></Reference><Reference><Citation>European Association for the Study of the LiverEuropean Association for the Study of the Liver. EASL Clinical Practice Guidelines on Hepatitis Delta Virus. J Hepatol (2023) 79(2):433–60. 10.1016/j.jhep.2023.05.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2023.05.001</ArticleId><ArticleId IdType="pubmed">37364791</ArticleId></ArticleIdList></Reference><Reference><Citation>Franchello A, Ghisetti V, Marzano A, Romagnoli R, Salizzoni M. Transplantation of Hepatitis B Surface Antigen-Positive Livers Into Hepatitis B Virus-Positive Recipients and the Role of Hepatitis Delta Coinfection. Liver Transpl (2005) 11(8):922–8. 10.1002/lt.20471</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lt.20471</ArticleId><ArticleId IdType="pubmed">16035057</ArticleId></ArticleIdList></Reference><Reference><Citation>Martini S, Tandoi F, Romagnoli R, Rizzetto M. Liver Transplantation in Hepatitis B/Hepatitis D (Delta) Virus Coinfected Recipients. Transplantation (2022) 106(10):1935–9. 10.1097/TP.0000000000004138</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TP.0000000000004138</ArticleId><ArticleId IdType="pubmed">35404869</ArticleId></ArticleIdList></Reference><Reference><Citation>Wedemeyer H, Aleman S, Brunetto MR, Blank A, Andreone P, Bogomolov P, et al. A Phase 3, Randomized Trial of Bulevirtide in Chronic Hepatitis D. N Engl J Med (2023) 389(1):22–32. 10.1056/NEJMoa2213429</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2213429</ArticleId><ArticleId IdType="pubmed">37345876</ArticleId></ArticleIdList></Reference><Reference><Citation>Bahde R, Holzen JP, Wolters HH, Schmidt HH, Bock CT, Lugering A, et al. Course of a HBsAg Positive Liver Transplantation in a Hepatitis B and D Virus Coinfected Recipient. Ann Hepatol (2011) 10(3):355–60. 10.1016/s1665-2681(19)31550-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1665-2681(19)31550-9</ArticleId><ArticleId IdType="pubmed">21677340</ArticleId></ArticleIdList></Reference><Reference><Citation>Huprikar S, Danziger-Isakov L, Ahn J, Naugler S, Blumberg E, Avery RK, et al. Solid Organ Transplantation From Hepatitis B Virus-Positive Donors: Consensus Guidelines for Recipient Management. Am J Transpl (2015) 15(5):1162–72. 10.1111/ajt.13187</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ajt.13187</ArticleId><ArticleId IdType="pubmed">25707744</ArticleId></ArticleIdList></Reference><Reference><Citation>Angelico M, Nardi A, Marianelli T, Caccamo L, Romagnoli R, Tisone G, et al. Hepatitis B-Core Antibody Positive Donors in Liver Transplantation and Their Impact on Graft Survival: Evidence From the Liver Match Cohort Study. J Hepatol (2013) 58(4):715–23. 10.1016/j.jhep.2012.11.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2012.11.025</ArticleId><ArticleId IdType="pubmed">23201239</ArticleId></ArticleIdList></Reference><Reference><Citation>Salas J, Storm K, Durand CM. Organ Donors With Human Immunodeficiency Virus and Hepatitis C Virus: Expanding the Donor Pool. Infect Dis Clin North Am (2023) 37(3):641–58. 10.1016/j.idc.2023.04.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idc.2023.04.003</ArticleId><ArticleId IdType="pubmed">37258326</ArticleId></ArticleIdList></Reference><Reference><Citation>Duong AT, Snyder HS, Billmeyer AL, Cox AC, Cheng NL, Ford RM, et al. Hepatitis C Donor Positive to Recipient Negative Solid Organ Transplants: Early Direct Acting Antiviral Insurance Approval Rates With and Without Documented Viremia. Am J Surg (2023) 226:239–44. 10.1016/j.amjsurg.2023.04.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjsurg.2023.04.015</ArticleId><ArticleId IdType="pubmed">37137788</ArticleId></ArticleIdList></Reference><Reference><Citation>Bekki Y, Crismale JF, Myers B, Schiano TD, Florman S. Varying Utilization Rates but Superior Outcomes in Liver Transplantation From Hepatitis C-Positive Donors in the United States: An Analysis of the OPTN/UNOS Database. Transplantation (2022) 106(9):1787–98. 10.1097/TP.0000000000004116</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TP.0000000000004116</ArticleId><ArticleId IdType="pubmed">35507448</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon JH, Hill MA, Patel R, Tedford RJ, Hashmi ZA, Shorbaji K, et al. Outcomes of over 1000 Heart Transplants Using Hepatitis C-Positive Donors in the Modern Era. Ann Thorac Surg (2023) 115(2):493–500. 10.1016/j.athoracsur.2022.11.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2022.11.002</ArticleId><ArticleId IdType="pubmed">36368348</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruck JM, Zeiser LB, Zhou AL, Chidi AP, Winchester SL, Durand CM, et al. Trends in Use and Three-Year Outcomes of Hepatitis C Virus-Viremic Donor Lung Transplants for Hepatitis C Virus-Seronegative Recipients. J Thorac Cardiovasc Surg (2023) 165(4):1587–95.e2. 10.1016/j.jtcvs.2022.08.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2022.08.019</ArticleId><ArticleId IdType="pmc">PMC9989038</ArticleId><ArticleId IdType="pubmed">36207160</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones JM, Kracalik I, Levi ME, Bowman JS, 3rd, Berger JJ, Bixler D, et al. Assessing Solid Organ Donors and Monitoring Transplant Recipients for Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Infection - U.S. Public Health Service Guideline, 2020. MMWR Recomm Rep (2020) 69(4):1–16. 10.15585/mmwr.rr6904a1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.rr6904a1</ArticleId><ArticleId IdType="pmc">PMC7337549</ArticleId><ArticleId IdType="pubmed">32584804</ArticleId></ArticleIdList></Reference><Reference><Citation>Gambato M, Perez-Del-Pulgar S, Hedskog C, Svarovskia ES, Brainard D, Denning J, et al. Hepatitis C Virus RNA Persists in Liver Explants of Most Patients Awaiting Liver Transplantation Treated With an Interferon-free Regimen. Gastroenterology (2016) 151(4):633–6. 10.1053/j.gastro.2016.06.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2016.06.025</ArticleId><ArticleId IdType="pubmed">27373513</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira BJ, Wright TL, Schmid CH, Levey AS. A Controlled Study of Hepatitis C Transmission by Organ Transplantation. The New England Organ Bank Hepatitis C Study Group. Lancet (1995) 345(8948):484–7. 10.1016/s0140-6736(95)90583-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(95)90583-9</ArticleId><ArticleId IdType="pubmed">7532254</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinfurtner K, Reddy KR. Hepatitis C Viraemic Organs in Solid Organ Transplantation. J Hepatol (2021) 74(3):716–33. 10.1016/j.jhep.2020.11.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2020.11.014</ArticleId><ArticleId IdType="pubmed">33212088</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon CE, Adam GP, Jadoul M, Martin P, Balk EM. Kidney Transplantation from Hepatitis C Virus-Infected Donors to Uninfected Recipients: A Systematic Review for the KDIGO 2022 Hepatitis C Clinical Practice Guideline Update. Am J Kidney Dis (2023) 82(4):410–8. 10.1053/j.ajkd.2022.12.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2022.12.019</ArticleId><ArticleId IdType="pubmed">37061019</ArticleId></ArticleIdList></Reference><Reference><Citation>Morales JM, Campistol JM, Dominguez-Gil B, Andres A, Esforzado N, Oppenheimer F, et al. Long-term Experience With Kidney Transplantation From Hepatitis C-Positive Donors into Hepatitis C-Positive Recipients. Am J Transpl (2010) 10(11):2453–62. 10.1111/j.1600-6143.2010.03280.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-6143.2010.03280.x</ArticleId><ArticleId IdType="pubmed">20977636</ArticleId></ArticleIdList></Reference><Reference><Citation>Woolley AE, Fanikos J, Baden LR. Heart and Lung Transplants From HCV-Infected Donors. Reply. Reply N Engl J Med (2019) 381(10):989. 10.1056/NEJMc1907009</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc1907009</ArticleId><ArticleId IdType="pubmed">31483978</ArticleId></ArticleIdList></Reference><Reference><Citation>Aleyadeh W, Verna EC, Elbeshbeshy H, Sulkowski MS, Smith C, Darling J, et al. Outcomes of Early vs Late Treatment Initiation in Solid Organ Transplantation From Hepatitis C Virus Nucleic Acid Test-Positive Donors to Hepatitis C Virus-Uninfected Recipients: Results From the HCV-TARGET Study. Am J Transpl (2023) 24:468–78. 10.1016/j.ajt.2023.10.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajt.2023.10.006</ArticleId><ArticleId IdType="pubmed">37871798</ArticleId></ArticleIdList></Reference><Reference><Citation>Saberi B, Hamilton JP, Durand CM, Li Z, Philosophe B, Cameron AM, et al. Utilization of Hepatitis C Virus RNA-Positive Donor Liver for Transplant to Hepatitis C Virus RNA-Negative Recipient. Liver Transpl (2018) 24(1):140–3. 10.1002/lt.24838</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lt.24838</ArticleId><ArticleId IdType="pmc">PMC6460912</ArticleId><ArticleId IdType="pubmed">28779557</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah KK, Wyld M, Hedley JA, Waller KMJ, De La Mata N, Webster AC, et al. Cost-Effectiveness of Kidney Transplantation From Donors at Increased Risk of Blood-Borne Virus Infection Transmission. Transplantation (2023) 107:2028–42. 10.1097/TP.0000000000004632</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TP.0000000000004632</ArticleId><ArticleId IdType="pubmed">37211651</ArticleId></ArticleIdList></Reference><Reference><Citation>Lushniak SA, Durand CM. Donors With Human Immunodeficiency Virus and Hepatitis C Virus for Solid Organ Transplantation: What's New. Curr Opin Infect Dis (2022) 35(4):321–9. 10.1097/QCO.0000000000000840</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QCO.0000000000000840</ArticleId><ArticleId IdType="pmc">PMC9718437</ArticleId><ArticleId IdType="pubmed">35849522</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller E, Botha FCJ, Barday ZA, Manning K, Chin-Hong P, Stock P. Kidney Transplantation in HIV-Positive Patients: Current Practice and Management Strategies. Transplantation (2021) 105(7):1492–501. 10.1097/TP.0000000000003485</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TP.0000000000003485</ArticleId><ArticleId IdType="pmc">PMC8026768</ArticleId><ArticleId IdType="pubmed">33044431</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandran S, Stock PG, Roll GR. Expanding Access to Organ Transplant for People Living With HIV:Can Policy Catch up to Outcomes Data? Transplantation (2023) 108:874–83. 10.1097/TP.0000000000004794</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TP.0000000000004794</ArticleId><ArticleId IdType="pubmed">37723620</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller E, Barday Z. HIV-Positive Kidney Donor Selection for HIV-Positive Transplant Recipients. J Am Soc Nephrol (2018) 29(4):1090–5. 10.1681/ASN.2017080853</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2017080853</ArticleId><ArticleId IdType="pmc">PMC5875954</ArticleId><ArticleId IdType="pubmed">29330339</ArticleId></ArticleIdList></Reference><Reference><Citation>Botha J, Conradie F, Etheredge H, Fabian J, Duncan M, Haeri Mazanderani A, et al. Living Donor Liver Transplant From an HIV-Positive Mother to Her HIV-Negative Child: Opening up New Therapeutic Options. AIDS (2018) 32(16):F13–F19. 10.1097/QAD.0000000000002000</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QAD.0000000000002000</ArticleId><ArticleId IdType="pmc">PMC6200383</ArticleId><ArticleId IdType="pubmed">30281558</ArticleId></ArticleIdList></Reference><Reference><Citation>Durand CM, Zhang W, Brown DM, Yu S, Desai N, Redd AD, et al. A Prospective Multicenter Pilot Study of HIV-Positive Deceased Donor to HIV-Positive Recipient Kidney Transplantation: HOPE in Action. Am J Transpl (2021) 21(5):1754–64. 10.1111/ajt.16205</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ajt.16205</ArticleId><ArticleId IdType="pmc">PMC8073960</ArticleId><ArticleId IdType="pubmed">32701209</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonny TS, Kirby C, Martens C, Rose R, Desai N, Seisa M, et al. Outcomes of Donor-Derived Superinfection Screening in HIV-Positive to HIV-Positive Kidney and Liver Transplantation: A Multicentre, Prospective, Observational Study. Lancet HIV (2020) 7(9):e611–9. 10.1016/S2352-3018(20)30200-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-3018(20)30200-9</ArticleId><ArticleId IdType="pmc">PMC8073978</ArticleId><ArticleId IdType="pubmed">32730756</ArticleId></ArticleIdList></Reference><Reference><Citation>Benner SE, Zhu X, Hussain S, Florman S, Eby Y, Fernandez RE, et al. HIV-Positive Liver Transplant Does Not Alter the Latent Viral Reservoir in Recipients with Antiretroviral Therapy-Suppressed HIV. J Infect Dis (2023) 228(9):1274–9. 10.1093/infdis/jiad241</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiad241</ArticleId><ArticleId IdType="pmc">PMC10629701</ArticleId><ArticleId IdType="pubmed">37379584</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemmersbach-Miller M, Wood RP, Wolfe CR. Donor Evaluation in the Era of HIV-Positive Organ Transplantation: The Importance of the Infectious Diseases Specialist. Am J Transpl (2020) 20(9):2589–92. 10.1111/ajt.15921</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ajt.15921</ArticleId><ArticleId IdType="pmc">PMC7540733</ArticleId><ArticleId IdType="pubmed">32301273</ArticleId></ArticleIdList></Reference><Reference><Citation>Durand CM, Werbel W, Doby B, Brown D, Desai NM, Malinis M, et al. Clarifying the HOPE Act Landscape: The Challenge of Donors With False-Positive HIV Results. Am J Transpl (2020) 20(2):617–9. 10.1111/ajt.15681</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ajt.15681</ArticleId><ArticleId IdType="pmc">PMC7132607</ArticleId><ArticleId IdType="pubmed">31675457</ArticleId></ArticleIdList></Reference><Reference><Citation>Werbel WA, Brown DM, Kusemiju OT, Doby BL, Seaman SM, Redd AD, et al. National Landscape of Human Immunodeficiency Virus-Positive Deceased Organ Donors in the United States. Clin Infect Dis (2022) 74(11):2010–9. 10.1093/cid/ciab743</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab743</ArticleId><ArticleId IdType="pmc">PMC9187316</ArticleId><ArticleId IdType="pubmed">34453519</ArticleId></ArticleIdList></Reference><Reference><Citation>Grossi PA. Risk Assessment for HIV+ Organ Donors: Is the CD4 T Cell Count a Marker of Increased Risk of Transmissible Diseases? Transplantation (2017) 101(4):684–5. 10.1097/TP.0000000000001626</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TP.0000000000001626</ArticleId><ArticleId IdType="pmc">PMC7228585</ArticleId><ArticleId IdType="pubmed">28045878</ArticleId></ArticleIdList></Reference><Reference><Citation>Durand CM, Martinez N, Neumann K, Benedict RC, Baker AW, Wolfe CR, et al. Living Kidney Donors With HIV: Experience and Outcomes From a Case Series by the HOPE in Action Consortium. Lancet Reg Health Am (2023) 24:100553. 10.1016/j.lana.2023.100553</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lana.2023.100553</ArticleId><ArticleId IdType="pmc">PMC10435840</ArticleId><ArticleId IdType="pubmed">37600163</ArticleId></ArticleIdList></Reference><Reference><Citation>Muzaale AD, Althoff KN, Sperati CJ, Abraham AG, Kucirka LM, Massie AB, et al. Risk of End-Stage Renal Disease in HIV-Positive Potential Live Kidney Donors. Am J Transpl (2017) 17(7):1823–32. 10.1111/ajt.14235</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ajt.14235</ArticleId><ArticleId IdType="pmc">PMC5489376</ArticleId><ArticleId IdType="pubmed">28497525</ArticleId></ArticleIdList></Reference><Reference><Citation>Durand CM, Florman S, Motter JD, Brown D, Ostrander D, Yu S, et al. HOPE in Action: A Prospective Multicenter Pilot Study of Liver Transplantation From Donors With HIV to Recipients With HIV. Am J Transpl (2022) 22(3):853–64. 10.1111/ajt.16886</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ajt.16886</ArticleId><ArticleId IdType="pmc">PMC9997133</ArticleId><ArticleId IdType="pubmed">34741800</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaul DR, Valesano AL, Petrie JG, Sagana R, Lyu D, Lin J, et al. Donor to Recipient Transmission of SARS-CoV-2 by Lung Transplantation Despite Negative Donor Upper Respiratory Tract Testing. Am J Transpl (2021) 21(8):2885–9. 10.1111/ajt.16532</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ajt.16532</ArticleId><ArticleId IdType="pmc">PMC8014875</ArticleId><ArticleId IdType="pubmed">33565705</ArticleId></ArticleIdList></Reference><Reference><Citation>Peghin M, Grossi PA. COVID-19 Positive Donor for Solid Organ Transplantation. J Hepatol (2022) 77(4):1198–204. 10.1016/j.jhep.2022.06.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2022.06.021</ArticleId><ArticleId IdType="pmc">PMC9251900</ArticleId><ArticleId IdType="pubmed">35798131</ArticleId></ArticleIdList></Reference><Reference><Citation>Eichenberger EM, Kaul DR, Wolfe CR. The Pandemic Provides a Pathway: What We Know and what We Need to Know About Using COVID Positive Donors. Transpl Infect Dis (2021) 23(5):e13727. 10.1111/tid.13727</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tid.13727</ArticleId><ArticleId IdType="pmc">PMC8646898</ArticleId><ArticleId IdType="pubmed">34612553</ArticleId></ArticleIdList></Reference><Reference><Citation>Eichenberger EM, Coniglio AC, Milano C, Schroder J, Bryner BS, Spencer PJ, et al. Transplanting Thoracic COVID-19 Positive Donors: An Institutional Protocol and Report of the First 14 Cases. J Heart Lung Transpl (2022) 41(10):1376–81. 10.1016/j.healun.2022.06.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.healun.2022.06.018</ArticleId><ArticleId IdType="pmc">PMC9245398</ArticleId><ArticleId IdType="pubmed">35871114</ArticleId></ArticleIdList></Reference><Reference><Citation>Madan S, Chan MAG, Saeed O, Hemmige V, Sims DB, Forest SJ, et al. Early Outcomes of Adult Heart Transplantation From COVID-19 Infected Donors. J Am Coll Cardiol (2023) 81(24):2344–57. 10.1016/j.jacc.2023.04.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2023.04.022</ArticleId><ArticleId IdType="pmc">PMC10191151</ArticleId><ArticleId IdType="pubmed">37204379</ArticleId></ArticleIdList></Reference><Reference><Citation>
HRSA. Summary of Current Evidence and Information– Donor SARS-CoV-2 Testing and Organ Recovery from Donors With a History of COVID-19 (2024). Available from: https://optn.transplant.hrsa.gov/media/kkhnlwah/sars-cov-2-summary-of-evidence.pdf (Accessed January, 2024).
</Citation></Reference><Reference><Citation>Asija R, Singh R, Paneitz DC, Wolfe SB, Chukwudi C, Michel E, et al. Is Transplantation With Coronavirus Disease 2019-Positive Donor Lungs Safe? A US Nationwide Analysis. Ann Thorac Surg (2023) 116(5):1046–54. 10.1016/j.athoracsur.2023.05.048</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2023.05.048</ArticleId><ArticleId IdType="pubmed">37506993</ArticleId></ArticleIdList></Reference><Reference><Citation>Saharia KK, Ramelli SC, Stein SR, Roder AE, Kreitman A, Banakis S, et al. Successful Lung Transplantation Using an Allograft from a COVID-19-Recovered Donor: A Potential Role for Subgenomic RNA to Guide Organ Utilization. Am J Transpl (2023) 23(1):101–7. 10.1016/j.ajt.2022.09.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajt.2022.09.001</ArticleId><ArticleId IdType="pmc">PMC9833374</ArticleId><ArticleId IdType="pubmed">36695611</ArticleId></ArticleIdList></Reference><Reference><Citation>Martini S, Saracco M, Cocchis D, Pittaluga F, Lavezzo B, Barisone F, et al. Favorable Experience of Transplant Strategy Including Liver Grafts From COVID-19 Donors: One-Year Follow-Up Results. Transpl Infect Dis (2023) 25:e14126. 10.1111/tid.14126</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tid.14126</ArticleId><ArticleId IdType="pubmed">37585372</ArticleId></ArticleIdList></Reference><Reference><Citation>Montiel Villalonga P, Martinez-Alpuente I, Fernandez-Ruiz M, Len O, Bodro M, Los-Arcos I, et al. Transplantation of Organs From SARS-CoV-2-Positive Donors: Preliminary Experience From Spain. Transpl Infect Dis (2023) 25(1):e14008. 10.1111/tid.14008</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tid.14008</ArticleId><ArticleId IdType="pubmed">36659870</ArticleId></ArticleIdList></Reference><Reference><Citation>Malinis M, Boucher HW, AST Infectious Diseases Community of Practice. Screening of Donor and Candidate Prior to Solid Organ Transplantation-Guidelines From the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transpl (2019) 33(9):e13548. 10.1111/ctr.13548</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ctr.13548</ArticleId><ArticleId IdType="pubmed">30900327</ArticleId></ArticleIdList></Reference><Reference><Citation>Boutin CA, Pouch SM, Ison MG. Utility of Deceased Donor Cultures in Solid Organ Transplantation in Preventing Donor-Derived Bacterial and Fungal Infectious Diseases Transmission. Transpl Infect Dis (2023) 25(2):e14032. 10.1111/tid.14032</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tid.14032</ArticleId><ArticleId IdType="pubmed">36748658</ArticleId></ArticleIdList></Reference><Reference><Citation>Lumbreras C, Sanz F, Gonzalez A, Perez G, Ramos MJ, Aguado JM, et al. Clinical Significance of Donor-Unrecognized Bacteremia in the Outcome of Solid-Organ Transplant Recipients. Clin Infect Dis (2001) 33(5):722–6. 10.1086/322599</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/322599</ArticleId><ArticleId IdType="pubmed">11477528</ArticleId></ArticleIdList></Reference><Reference><Citation>Siddiqi U, Blitzer D, Lirette S, Patel A, Hoang R, Mohammed A, et al. Positive Donor Blood Cultures Are Not Associated With Worse Heart Transplant Survival. Clin Transpl (2023) 37:e14994. 10.1111/ctr.14994</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ctr.14994</ArticleId><ArticleId IdType="pubmed">37062052</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolfe CR, Ison MG, AST Infectious Diseases Community of Practice. Donor-derived Infections: Guidelines From the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transpl (2019) 33(9):e13547. 10.1111/ctr.13547</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ctr.13547</ArticleId><ArticleId IdType="pubmed">30903670</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao J, Wu D, Jia Y, Wan Q, Peng J. Impact of Donor-Derived Multi-Drug-Resistant Organism Infections on Abdominal Solid Organ Transplantation Recipients in China. Transpl Proc (2021) 53(6):1853–7. 10.1016/j.transproceed.2021.04.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.transproceed.2021.04.014</ArticleId><ArticleId IdType="pubmed">33994182</ArticleId></ArticleIdList></Reference><Reference><Citation>Doucette KE, Al-Saif M, Kneteman N, Chui L, Tyrrell GJ, Kumar D, et al. Donor-Derived Bacteremia in Liver Transplant Recipients Despite Antibiotic Prophylaxis. Am J Transpl (2013) 13(4):1080–3. 10.1111/ajt.12133</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ajt.12133</ArticleId><ArticleId IdType="pubmed">23398841</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh N. Impact of Donor Bacteremia on Outcome in Organ Transplant Recipients. Liver Transpl (2002) 8(10):975–6. 10.1053/jlts.2002.0080975</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/jlts.2002.0080975</ArticleId><ArticleId IdType="pubmed">12360445</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhall GHB, Robb ML, Brown C, Johnson RJ, Tomlinson LA, Callaghan CJ, et al. Solid Organ Transplantation From Deceased Donors With Infective Endocarditis: The UK Experience. Transplantation (2022) 106(3):588–96. 10.1097/TP.0000000000003792</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TP.0000000000003792</ArticleId><ArticleId IdType="pubmed">33901109</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh N, Huprikar S, Burdette SD, Morris MI, Blair JE, Wheat LJ, American Society of Transplantation IDCoPD-DFIWG. Donor-Derived Fungal Infections in Organ Transplant Recipients: Guidelines of the American Society of Transplantation, Infectious Diseases Community of Practice. Am J Transpl (2012) 12(9):2414–28. 10.1111/j.1600-6143.2012.04100.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-6143.2012.04100.x</ArticleId><ArticleId IdType="pubmed">22694672</ArticleId></ArticleIdList></Reference><Reference><Citation>Anjan S, Simkins J, Ciancio G, Natori Y, Guerra G. 218.4: Outcomes of Donor Candidemia in Kidney Transplant Recipients: A Single center Experience. Transplantation (2023) 107:50. 10.1097/01.tp.0000993268.99474.b5</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.tp.0000993268.99474.b5</ArticleId></ArticleIdList></Reference><Reference><Citation>Graziano E, Peghin M, Grossi PA. Perioperative Antibiotic Stewardship in the Organ Transplant Setting. Transpl Infect Dis (2022) 24(5):e13895. 10.1111/tid.13895</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tid.13895</ArticleId><ArticleId IdType="pmc">PMC9788034</ArticleId><ArticleId IdType="pubmed">35781915</ArticleId></ArticleIdList></Reference><Reference><Citation>Pouch SM, Ison MG. Deceased Donors With Multidrug-Resistant Organisms: Implications and Future Directions. Curr Opin Organ Transpl (2022) 27(4):250–6. 10.1097/MOT.0000000000000991</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MOT.0000000000000991</ArticleId><ArticleId IdType="pubmed">36354250</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesi JA, Han JH, Lautenbach E, Lee DH, Clauss H, Climaco A, et al. Impact of Deceased Donor Multidrug-Resistant Bacterial Organisms on Organ Utilization. Am J Transpl (2020) 20(9):2559–66. 10.1111/ajt.15830</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ajt.15830</ArticleId><ArticleId IdType="pmc">PMC7483863</ArticleId><ArticleId IdType="pubmed">32090413</ArticleId></ArticleIdList></Reference><Reference><Citation>Procaccio F, Masiero L, Vespasiano F, Grossi PA, Gagliotti C, Pantosti A, et al. Organ Donor Screening for Carbapenem-Resistant Gram-Negative Bacteria in Italian Intensive Care Units: The DRIn Study. Am J Transpl (2020) 20(1):262–73. 10.1111/ajt.15566</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ajt.15566</ArticleId><ArticleId IdType="pubmed">31400257</ArticleId></ArticleIdList></Reference><Reference><Citation>Pouch SM, Patel G, AST Infectious Diseases Community of Practice. Multidrug-Resistant Gram-Negative Bacterial Infections in Solid Organ Transplant Recipients-Guidelines From the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transpl (2019) 33(9):e13594. 10.1111/ctr.13594</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ctr.13594</ArticleId><ArticleId IdType="pubmed">31102483</ArticleId></ArticleIdList></Reference><Reference><Citation>Escola-Verge L, Los-Arcos I, Jose Gonzalez-Lopez J, Lung M, Bilbao I, Farre M, et al. Successful Liver Transplantation Despite Donor‐transmitted ESBL‐producing Klebsiella Pneumoniae Infection: Case Report and Review of the Literature. Transpl Infect Dis (2017) 19(5). 10.1111/tid.12743</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tid.12743</ArticleId><ArticleId IdType="pubmed">28691772</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis JD, Sifri CD. Multidrug-Resistant Bacterial Donor-Derived Infections in Solid Organ Transplantation. Curr Infect Dis Rep (2016) 18(6):18. 10.1007/s11908-016-0526-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11908-016-0526-9</ArticleId><ArticleId IdType="pubmed">27115701</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong L, Hu XG, Huang F, Huang SW, Li LF, Tang ZX, et al. Clinical Impacts and Outcomes With Possible Donor-Derived Infection in Infected Donor Liver Transplantation: A Single-Center Retrospective Study in China. J Infect Dis (2020) 221(Suppl. 2):S164–S173. 10.1093/infdis/jiz591</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiz591</ArticleId><ArticleId IdType="pubmed">32176783</ArticleId></ArticleIdList></Reference><Reference><Citation>Mularoni A, Bertani A, Vizzini G, Gona F, Campanella M, Spada M, et al. Outcome of Transplantation Using Organs From Donors Infected or Colonized With Carbapenem-Resistant Gram-Negative Bacteria. Am J Transpl (2015) 15(10):2674–82. 10.1111/ajt.13317</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ajt.13317</ArticleId><ArticleId IdType="pubmed">25981339</ArticleId></ArticleIdList></Reference><Reference><Citation>Ariza-Heredia EJ, Patel R, Blumberg EA, Walker RC, Lewis R, Evans J, et al. Outcomes of Transplantation Using Organs From a Donor Infected With Klebsiella pneumoniae Carbapenemase (KPC)-Producing K. pneumoniae . Transpl Infect Dis (2012) 14(3):229–36. 10.1111/j.1399-3062.2012.00742.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-3062.2012.00742.x</ArticleId><ArticleId IdType="pubmed">22624726</ArticleId></ArticleIdList></Reference><Reference><Citation>Mularoni A, Cona A, Campanella M, Barbera F, Medaglia AA, Cervo A, et al. Donor-Derived Carbapenem-Resistant Gram-Negative Bacterial Infections in Solid Organ Transplant Recipients: Active Surveillance Enhances Recipient Safety. Am J Transpl (2024) 24(6):1046–56. 10.1016/j.ajt.2024.02.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajt.2024.02.005</ArticleId><ArticleId IdType="pubmed">38342183</ArticleId></ArticleIdList></Reference><Reference><Citation>Sui M, Zheng N, Xu D, Li Y, Li Y, Pu S, et al. Colistin Sulfate for Decontamination of Preservation Fluid in Kidney Transplantation to Decrease the Incidence of Donor-Derived Infections Caused by Multidrug-Resistant Gram-Negative Bacteria. Transpl Infect Dis (2022) 24(3):e13820. 10.1111/tid.13820</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tid.13820</ArticleId><ArticleId IdType="pubmed">35279926</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesi JA, Blumberg EA, Han JH, Lee DH, Clauss H, Hasz R, et al. Impact of Donor Multidrug-Resistant Organisms on Solid Organ Transplant Recipient Outcomes. Transpl Infect Dis (2022) 24(1):e13783. 10.1111/tid.13783</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tid.13783</ArticleId><ArticleId IdType="pmc">PMC9495582</ArticleId><ArticleId IdType="pubmed">34968006</ArticleId></ArticleIdList></Reference><Reference><Citation>Benamu E, Pereira MR, Taimur S, Jacobs SE, Friedman AL, Jenkins SG, et al. Isolation of Antibiotic-Resistant Gram-Negative Organisms from Donor Respiratory Culture Does Not Impact Non-lung Solid Organ Recipient Management. Clin Transpl (2019) 33(8):e13646. 10.1111/ctr.13646</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ctr.13646</ArticleId><ArticleId IdType="pubmed">31230392</ArticleId></ArticleIdList></Reference><Reference><Citation>Bunsow E, Los-Arcos I, Martin-Gomez MT, Bello I, Pont T, Berastegui C, et al. Donor-Derived Bacterial Infections in Lung Transplant Recipients in the Era of Multidrug Resistance. J Infect (2020) 80(2):190–6. 10.1016/j.jinf.2019.12.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2019.12.006</ArticleId><ArticleId IdType="pubmed">31843689</ArticleId></ArticleIdList></Reference><Reference><Citation>Azar MM, Turbett SE, Fishman JA, Pierce VM. Donor-Derived Transmission of Candida Auris During Lung Transplantation. Clin Infect Dis (2017) 65(6):1040–2. 10.1093/cid/cix460</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/cix460</ArticleId><ArticleId IdType="pubmed">28520901</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>